Journal
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY
Volume 54, Issue 1, Pages 89-93Publisher
JAPANESE SOC LYMPHORETICULAR TISSUE RESEARCH
DOI: 10.3960/jslrt.54.89
Keywords
multiple myeloma; survival; bortezomib; lenalidomide; risk factors